This webinar, hosted by Baker Institute ambassador Matt Keenan features the Head of Preclinical Disease and Prevention Associate Professor Melinda Carrington.
They discuss what personalised medicine is and how it can revolutionise the way we predict and treat heart disease and diabetes.